Fibrinogen deficiency is compatible with the development of atherosclerosis in mice
- PMID: 9486990
- PMCID: PMC508671
- DOI: 10.1172/JCI1461
Fibrinogen deficiency is compatible with the development of atherosclerosis in mice
Abstract
A critical role of the coagulation system in the development of atherosclerosis has been frequently postulated based on a variety of indirect observations, including the expression of procoagulants and fibrinolytic factors within atherosclerotic vessels, the presence of substantial amounts of fibrin(ogen) and fibrin degradation products within intimal lesions, the cellular infiltration and assimilation of mural thrombi into developing plaques, and the identification of high plasma fibrinogen (Fib) levels as an independent risk factor for the development of ischemic heart disease. To directly examine the role of fibrin(ogen) in atherogenesis, Fib-deficient mice were crossed to atherosclerosis-prone apolipoprotein E (apo E)-deficient mice. Both apo E-/- and apo E-/-/Fib-/- mice developed lesions throughout the entire aortic tree, ranging in appearance from simple fatty streaks to complex fibrous plaques. Furthermore, remarkably little difference in lesion size and complexity was observed within the aortae of age- and gender-matched apo E-/- and apo E-/-/Fib-/- mice. These results indicate that the contribution of fibrin(ogen) to intimal mass and local cell adhesion, migration, and proliferation is not strictly required for the development of advanced atherosclerotic disease in mice with a severe defect in lipid metabolism.
Similar articles
-
Fibrinogen deficiency reduces vascular accumulation of apolipoprotein(a) and development of atherosclerosis in apolipoprotein(a) transgenic mice.Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12591-5. doi: 10.1073/pnas.95.21.12591. Proc Natl Acad Sci U S A. 1998. PMID: 9770530 Free PMC article.
-
The localization of tissue factor and apolipoprotein(a) in atherosclerotic lesions of the human aorta and their relation to fibrinogen-fibrin transition.Pathol Res Pract. 1996 Mar;192(3):224-32. doi: 10.1016/S0344-0338(96)80225-1. Pathol Res Pract. 1996. PMID: 8739469
-
[Apo B, fibrinogen-fibrin and fibronectin in the intima of the normal human aorta and large arteries and in atherosclerosis].Arkh Patol. 1990;52(4):16-21. Arkh Patol. 1990. PMID: 2201275 Russian.
-
Fibrinogen, fibrin and fibrin degradation products in relation to atherosclerosis.Clin Haematol. 1986 May;15(2):355-70. Clin Haematol. 1986. PMID: 3524931 Review.
-
Fibrinogen/fibrin in atherogenesis.Eur J Epidemiol. 1992 May;8 Suppl 1:83-7. doi: 10.1007/BF00145356. Eur J Epidemiol. 1992. PMID: 1387095 Review.
Cited by
-
Blood coagulation and the risk of atherothrombosis: a complex relationship.Thromb J. 2004 Dec 1;2(1):12. doi: 10.1186/1477-9560-2-12. Thromb J. 2004. PMID: 15574198 Free PMC article.
-
Factor V Leiden but not the factor II 20210G>A mutation is a risk factor for premature coronary artery disease: a case-control study in Iran.Res Pract Thromb Haemost. 2023 Jan 11;7(1):100048. doi: 10.1016/j.rpth.2023.100048. eCollection 2023 Jan. Res Pract Thromb Haemost. 2023. PMID: 36798900 Free PMC article.
-
PPARalpha deficiency reduces insulin resistance and atherosclerosis in apoE-null mice.J Clin Invest. 2001 Apr;107(8):1025-34. doi: 10.1172/JCI11497. J Clin Invest. 2001. PMID: 11306606 Free PMC article.
-
Molecular MRI of atherosclerosis.Molecules. 2013 Nov 13;18(11):14042-69. doi: 10.3390/molecules181114042. Molecules. 2013. PMID: 24232739 Free PMC article. Review.
-
Pleiotropic actions of factor Xa inhibition in cardiovascular prevention: mechanistic insights and implications for anti-thrombotic treatment.Cardiovasc Res. 2021 Jul 27;117(9):2030-2044. doi: 10.1093/cvr/cvaa263. Cardiovasc Res. 2021. PMID: 32931586 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases